A new, powerful Citizen Portal experience is ready. Switch now

House committee advances cannabis 'streamlining' bill after heated debate over canopy limits

May 16, 2026 | 2026 Legislature MN, Minnesota


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

House committee advances cannabis 'streamlining' bill after heated debate over canopy limits
The Minnesota House Ways and Means Committee voted to advance Senate File 4401, a comprehensive package to ‘streamline’ the state’s medical and adult-use cannabis system, after several hours of debate and testimony over limits on grow-space — known as 'canopy' — and whether changes would unfairly harm specific incumbent businesses.

Representative Lindsey Hansen, the bill’s sponsor, told the committee the DE aligns House and Senate language and includes provisions to merge medical and adult-use supply chains, require faster testing for high-need medical products, clarify labeling and data practices, and create a bridge for hemp businesses seeking to move into cannabis. "We are trying to right-size the market," Hansen said, adding the office would retain authority to increase canopy if market demand warrants.

The most contested issue was an A1 amendment introduced by Representative Allen West that would have required the Office of Cannabis Management to prioritize increases in canopy for macro businesses that held licenses before January 2026. West said the amendment was intended to prevent an incumbent operator — which has invested in an Elk River facility — from losing a multimillion-dollar investment. "This would at least create a path for that damage to be undone by the department," West said.

Opponents argued the amendment would "pick winners and losers." Representative Scott and others asked whether the language would give preferential treatment to one or two companies; Representative Kotyza-Witthuhn and Representative Klevorn said committee members were uncomfortable appearing to advocate for a particular business. Hansen responded that canopy numbers in the bill were based on measurements performed by the Office of Cannabis Management and that any future canopy increases should apply industrywide.

Eric Copple, executive director of the Minnesota Office of Cannabis Management, testified that OCM conducted site measurements as the State converted the prior registration system to the new licensing framework. Copple said initial measurements at two incumbent facilities produced combined canopy figures in the 30,000–38,000 square-foot range (medical plus adult-use halves in the conversion), and that the office has repeatedly reached out to incumbent providers and other stakeholders during drafting. "We measured each of them to determine their current medical canopy and then under the law they were entitled to move half of that to adult use," Copple said.

Representatives of the company building the Elk River facility, including Amber Ship, who identified herself as CEO of Your Real Health of Minnesota, and a company representative at the witness table, said the firm relied on the prior 2023 law that allowed larger canopy in planning and investing roughly $30 million and expected to create roughly 100 jobs. "We participated in stakeholder engagement and had early indications about our planned canopy reduction; we strongly oppose the canopy cut in this bill," Ship told the committee.

A roll-call vote on the A1 amendment ended in a 14–14 tie and the amendment failed. Later in the meeting a different amendment to the DE passed on a 15–13 roll-call. After the DE was amended, the committee voted to move Senate File 4401, as amended, to the General Register.

The bill includes multiple agency bills and technical changes affecting licensing categories, allowable owners and ownership caps, event licensing, civil penalties, and labeling and testing rules. Hansen said the bill aims to prioritize patient access to high-need medical products and to reduce duplicative reporting while providing pathways for small businesses and social-equity applicants.

What happens next: the bill goes to the General Register for further consideration by the full House. The Office of Cannabis Management and stakeholders have opportunities to continue providing input as language is considered by other committees and, if passed, reconciled with the Senate version.

View the Full Meeting & All Its Details

This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.

Watch full, unedited meeting videos
Search every word spoken in unlimited transcripts
AI summaries & real-time alerts (all government levels)
Permanent access to expanding government content
Access Full Meeting

30-day money-back guarantee